Inhibitory effects of thymoquinone, the major component of Nigella sativa L. seeds, on spontaneous and evoked contractions of guinea pig isolated ileum

Journal of Medicinal Plants

Volumn 6, Issue 23, 2007, Pages

  Parvardeh, S ^a   Fatehi, M ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Calcium channels; Guinea pig ileum; Tension recording; Thymoquinone

Indexed keywords

ACETYLCHOLINE; CALCIUM CHANNEL; CALCIUM CHLORIDE; HISTAMINE; NIGELLA SATIVA EXTRACT; POTASSIUM CHLORIDE; THYMOQUINONE;

ANIMAL TISSUE; ARTICLE; BLACK CUMIN; CITRIC ACID CYCLE; CONTROLLED STUDY; ELECTROSTIMULATION; EVOKED MUSCLE RESPONSE; GUINEA PIG; ILEUM CONTRACTION; NONHUMAN; PLANT SEED; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE RELAXATION; TRANSDUCER;

CAVIA; NIGELLA SATIVA;

EID: 40449091206     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ali BH and Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother. Res. 2003; 17: 299-305.
2. Aqel-Mahmoud B. The relaxing effects of the volatile oil of Nigella sativa seeds on vascular smooth muscle. Dirasat Series B. Pure Appl. Sci. 1993; 19: 91-100.
3. El-Tahir KEH, Al-Tahir AY, and Ageel AM. Pharmacological studies on sesame and Nigella sativa fixed oil: Effects on the sensitivities of the adrenoceptors, baroreceprors, platelets and the uterus of the rat. Saudi. Pharmac. J. 1997; 7: 205-215.
4. El-Tahir KEH, Ashour MMS, and Al-Harbi MM. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: Elucidation of the mechanism of action. Gen. Pharmacol. 1993; 24: 1123-1131.
5. Zaoui A, Cherrah Y, Lacaille-Dubois MA, Settaf A, Amarouch H, and Hassar M. Diuretic and hypotensive effects of Nigella sativa on the spontaneously hypertensive rat. Therapie 2000; 55: 379-382.
6. Aqel-Mahmoud B. Effects of Nigella sativa seeds on intestinal smooth muscle. Int. J. Pharmacol. 1993; 31: 55-60.
7. Gilani AH, Aziz N, and Khurram M. Bronchodilator, Spasmolytic and calcium antagonist activities of Nigella sativa seeds (Kalonji): a traditional herbal product with multiple medicinal uses. J. Pak. Med. Assoc. 2001; 51: 115-120.
8. Aqel-Mahmoud B. The calcium antagonistic effect of the volatile oil of Nigella sativa seeds. Dirasat Series B. Pure Appl. Sci. 1993; 19: 119-133.
9. Boskabady MH, and Shahabi M. Bronchodilatory and anticholinergic effects of Nigella sativa on isolated guinea pig tracheal chains. Ir. J. Med. Sci. 1997; 22: 127-133.
10. Boskabady MH and Sheiravi N. Inhibitory effects of Nigella sativa on histamine (H1) receptors of isolated guinea pig tracheal chains. Pharmac. Biol. 2002; 40: 596-602.
11. Boskabady MH, Shirmohammadi B, Jandaghi P and Kiani S. Possible mechanism (s) for relaxant effects of aqueous and macerated extracts from Nigella sativa on tracheal chains of guinea pig. BMC Pharmacol. 2004; 4: 3.
12. Aqel M and Shaheen R. Effects of the volatile oil of Nigella sativa seeds on the uterine smooth muscle of rat and guinea pig. J. Ethnopharmacol. 1996; 52: 23-26.
13. Filippo D'Antuono L, Moretti A, and Lovato AFS. Seed yield, yield components, oil content and essential oil content and composition of Nigella sativa L. and Nigella damascena L. Indust. Crops. Prod. 2002; 15: 59-69.
14. Parvardeh S and Hosseinzadeh H. Hypnosis and muscular relaxant activity of thymoquinet of Nigella sativa seeds and its effect on locomotion and coordination in mice. Medicinal Plants 2003; 2, 17-25.
15. Parvardeh S, Nasiri Asl M, Hossinzadeh H. Protective effects of thymoquinone against ischemia-reperfusion injury in rat brain. Iranian Journal of Basic Medical Sciences 2004; 7: 65-70.
16. Parvardeh S and Hosseinzadeh H. Role of opioid receptors on anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa, in mice. Iranian Journal of Basic Medical Sciences 2003; 6: 202-206.
17. Hosseinzadeh H, and Parvardeh S. Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine 2004; 11: 56-64.
18. Hosseinzadeh H, Parvardeh S, Nassiri-Asl M, and Mansouri MT. Intra-cerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats. Med. Sci. Monit. 2005; 11, 106-110.
19. Abdel-Fattah AM, Matsumoto K, and Watanabe H. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur. J. Pharmacol. 2000; 400: 89-97.
20. Houghton PI, Zarka R, Delas Heras B and Hoult RS. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med. 1995; 61: 33-36.
21. Badary OA. Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice. J. Ethnopharmacol. 1999; 67: 135-142.
22. Gali-Muhtasib HU, Abou Kheir WG, Kheir LA, Darwiche N and Crooks PA. Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anticancer Drugs 2004; 15: 389-399.
23. Hassan M and El-Dakhakhny M. Effect of some Nigella sativa Constituents on chemical carcinogenesis in hamster cheek pouch. J. Egypt. Soci. Pharmacol. Exp. Ther. 1992; 11: 675-677.
24. Worthen DR, Ghosheh OA and Crooks PA. The in vitro anti-tumor activity of some crude and purified components of black seed, Nigella sativa L. Anticancer Res. 1998; 18 (3 A): 1527-1532.
25. Al-Gharably NM, Badary OA, Nagi MN, Al-Shabanah OA, Al-Sawaf HA, Al-Rikabi AC. Protective effect of thymoquinone against carbon tetrachloride-induced hepatotoxicity in mice. Res. Commun. Pharmacol. Toxicol. 1997; 2: 41-50.
26. Daba MH and Abdel-Rahman MS. Hepatoprotective activity of thymoquinone in isolated rathepatocytes. Toxicol. Lett. 1998; 95: 23-9.
27. Nagi MN, Alam K, Badary OA, al-Shabanah OA, al-Sawaf HA and Al-Bekairi AM. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem. Mol. Biol. Int. 1999; 47: 153-159.
28. Badary OA, Nagi MN, Al-Shabanah OA, Al-Sawaf HA, Al-Sohaibani MO and Al-Bekairi AM. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can. J. Physiol. Pharmacol. 1997; 75: 1356-1361.
29. Al-Majed AA, Daba MH, Asiri YA, Al-Shabanah OA, Mostafa AA and El-Kashef HA. Thymoquinone-induced relaxation of guinea-pig isolated trachea. Res. Commun. Mol. Pathol. Pharmacol. 2001; 110: 333-345.
30. Daniel EE, Kwan CY and Janssen L. Pharmacological techniques for the in vitro study of intestinal smooth muscles. J. Pharmacol. Toxicol. Meth. 2000; 45: 141-158.
31. Eglen RM, Reddy H, Watson N and Chalks RAJ. Muscarinic receptor subtypes and smooth muscle function. Pharmacol. Rev. 1996; 48: 531-565.
32. Bolton TB. Mechanism of action of transmitters and other substances on smooth muscle. Physiol. Rev. 1979; 59: 606-718.
33. Godfraind T, Miller R and Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol. Rev. 1986; 38: 321-416.
34. Scherkl R, Hashem A and Frey HH. Histamine in brain: its role in regulation of seizure susceptibility. Epilepsy Res. 1991; 10: 111-118.
35. Yokoyama H, Onodera K, Iinuma K and Watanabe T. 2-Thiazolylethylamine, a selective histamine H1 agonist, decreases seizure susceptibility in mice. Pharmacol. Biochem. Behav. 1994; 47: 503-507.
36. Yokoyama H, Onodera K, Maeyama K, Yanai K, Iinuna K, Tuomisto L and Watanabe T. Histamine levels and clonic convulsions of electrically-induced seizures in mice. Naunyn Schmiedeberg's Arch. Pharmacol. 1992; 346: 40-45.
37. Horowitz B, Ward SM and Sanders KM. Cellular and molecular basis for electrical rhythmicity in gastrointestinal muscles. Annu. Rev. Physiol. 1999; 61: 19-43.